Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06064669 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Metformin on Healthy Live Birth in Women With Prediabetes

Study acronym: MELT-PreDM
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2023 to Feb 22, 2024
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the efficacy and safety of metformin pretreatment on reproductive outcomes in infertile women with prediabetes.
Trial Details
NCT Number NCT06064669
Lead Sponsor Shandong University
Collaborators: Ren Ji Hospital of Shanghai Jiao Tong University, Women's Hospital School Of Medicine Zhejiang University, Shengjing Hospital, Nanjing Medical University, General Hospital of Ningxia Medical University, West China Second University Hospital, Henan Provincial Maternal and Child Health Care Hospital, Qingdao women's and children's Hospital
Conditions
(from sponsor)		 Metformin, Prediabetes, In-Vitro Fertilization
Related terms Prediabetic State
Enrollment 988 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov